These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4103706)

  • 21. Atypical measles in adolescent siblings 16 years after killed measles virus vaccine.
    Fulginiti VA; Helfer RE
    JAMA; 1980 Aug 22-29; 244(8):804-6. PubMed ID: 7392190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Central nervous complications following measles vaccination].
    Dietzsch HJ; Kiehl W
    Dtsch Gesundheitsw; 1976 Dec; 31(52):2489-91. PubMed ID: 1009851
    [No Abstract]   [Full Text] [Related]  

  • 23. Measles vaccine: immunity, reinfection and revaccination.
    Linnemann CC
    Am J Epidemiol; 1973 Jun; 97(6):365-71. PubMed ID: 4713932
    [No Abstract]   [Full Text] [Related]  

  • 24. Mass immunization of children in Iran with live attenuated Sugiyama measles virus adapted to calf kidney cell cultures.
    Mirchamsy H; Shafyi A; Bahrami S; Nazari P; Mirzadeh M; Bassali Y
    Jpn J Exp Med; 1971 Feb; 41(1):39-48. PubMed ID: 5313449
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunisation of 4-6 month old Gambian infants with Edmonston-Zagreb measles vaccine.
    Whittle HC; Rowland MG; Mann GF; Lamb WH; Lewis RA
    Lancet; 1984 Oct; 2(8407):834-7. PubMed ID: 6148572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Measles vaccination of pre-school children: a detailed study of reaction frequency and side effects after immunization with vaccine of 3 different strengths].
    Böttiger M; Heller L; Kamensky P; Svanberg B
    Lakartidningen; 1974 Sep; 71(36):3270-4. PubMed ID: 4410083
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies on further attenuated live measles vaccine. 3. Selection of less reactive variants of CAM measles vaccine virus.
    Takaku K; Sasada T; Konobe T; Onishi K; Ueda S
    Biken J; 1970 Sep; 13(3):163-8. PubMed ID: 5530510
    [No Abstract]   [Full Text] [Related]  

  • 28. Experiences in mass prevention of measles by vaccination.
    Perkins FT
    Trans R Soc Trop Med Hyg; 1975; 69(1):24-5. PubMed ID: 1145714
    [No Abstract]   [Full Text] [Related]  

  • 29. Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial.
    Dilraj A; Cutts FT; de Castro JF; Wheeler JG; Brown D; Roth C; Coovadia HM; Bennett JV
    Lancet; 2000 Mar; 355(9206):798-803. PubMed ID: 10711928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurological complications following measles vaccination.
    Allerdist H
    Dev Biol Stand; 1979; 43():259-64. PubMed ID: 520673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measles vaccine reactions in a virgin population.
    Black FL; Woodall JP; Pinheiro FD
    Am J Epidemiol; 1969 Feb; 89(2):168-75. PubMed ID: 5765956
    [No Abstract]   [Full Text] [Related]  

  • 32. [Unsuitability of children revaccination against measles].
    Bolotovskiĭ VM; Titova NS
    Sov Med; 1981; (9):43-8. PubMed ID: 7313794
    [No Abstract]   [Full Text] [Related]  

  • 33. [Program for carrying out a campaign of controlled measles vaccination in a local area].
    Santoro R; Polo M; Rigoli E; Scardellato U; Annesi I; Grandolfo ME; Novello F
    Ann Ist Super Sanita; 1982; 18(3):441-4. PubMed ID: 7187830
    [No Abstract]   [Full Text] [Related]  

  • 34. Booster vaccination with further live attenuated measles vaccine.
    Bass JW; Halstead SB; Fischer GW; Podgore JK; Pearl WR; Schydlower M; Wiebe RA; Ching FM
    JAMA; 1976 Jan; 235(1):31-4. PubMed ID: 945997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The national vaccination program against measles].
    Cohen H; Brouwer R; Bijkerk H; Phaff JM
    Ned Tijdschr Geneeskd; 1978 Jan; 122(2):46-51. PubMed ID: 619292
    [No Abstract]   [Full Text] [Related]  

  • 36. Haemagglutination inhibition antibody levels one year after natural measles infection and vaccination.
    Eghafona NO; Ahmad AA; Ezeokoli CD; Emejuaiwe SO
    Microbios; 1991; 67(274):33-6. PubMed ID: 1758308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative study on two further attenuated live measles virus vaccines, "CAM" and "Moraten".
    Sangkawibha N; Tuchinda P; Bukkavesa S; Osatanonda P; Ueda S
    Biken J; 1971 Mar; 14(1):77-9. PubMed ID: 5090682
    [No Abstract]   [Full Text] [Related]  

  • 38. Attenuated measles virus vaccine dosage study--Cleveland, Ohio, 1966.
    Calafiore DC; Nader PR; Lepow ML; Nankervis GA; Casey H; Warren RJ
    Am J Epidemiol; 1968 Jan; 87(1):247-53. PubMed ID: 5637875
    [No Abstract]   [Full Text] [Related]  

  • 39. [Experiment of vaccination against measles using attenuated virus (Schwarz strain) (author's transl)].
    Trivello R; Renzulli G; Romano M; Milone G; Moschen ME
    Ann Sclavo; 1978; 20(2):113-20. PubMed ID: 742926
    [No Abstract]   [Full Text] [Related]  

  • 40. Successful immunization of children with and without maternal antibody by aerosolized measles vaccine. I. Different results with undiluted human diploid cell and chick embryo fibroblast vaccines.
    Sabin AB; Flores Arechiga A; Fernández de Castro J; Sever JL; Madden DL; Shekarchi I; Albrecht P
    JAMA; 1983 May; 249(19):2651-62. PubMed ID: 6341638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.